Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Kobayashi Pharmaceutical Co., Ltd.    4967   JP3301100008

KOBAYASHI PHARMACEUTICAL CO., LTD.

(4967)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Kobayashi Pharmaceutical Co Ltd : quaterly earnings release

share with twitter share with LinkedIn share with facebook
10/24/2018 | 10:15am EDT

The company will report its earnings for Q3 2018 on 10/29/2018. Generally, the company reports earnings in line with the consensus. In recent months, the 5 analysts from Thomson Reuters consensus have not revised their EPS estimates.


© MarketScreener.com 2018

share with twitter share with LinkedIn share with facebook
All news about KOBAYASHI PHARMACEUTICAL CO., LTD.
06/29KOBAYASHI PHARMACEUTICAL CO., LTD. : Ex-dividend day for interim dividend
FA
2019KOBAYASHI PHARMACEUTICAL CO LTD : Ex-dividend day for final dividend
FA
2019KOBAYASHI PHARMACEUTICAL CO LTD : Ex-dividend day for interim dividend
FA
2018KOBAYASHI PHARMACEUTICAL CO LTD : Ex-dividend day for final dividend
FA
2018KOBAYASHI PHARMACEUTICAL CO LTD : quaterly earnings release
2018KOBAYASHI PHARMACEUTICAL CO LTD : Ex-dividend day for interim dividend
FA
2017KOBAYASHI PHARMACEUTICAL CO LTD : Ex-dividend day for final dividend
FA
2017KOBAYASHI PHARMACEUTICAL CO LTD : Ex-dividend day for interim dividend
FA
2017KOBAYASHI PHARMACEUTICAL : Notice Concerning Proxy Voting Policy in The Kobayash..
PU
2016KOBAYASHI PHARMACEUTICAL CO LTD : Ex-dividend day for final dividend
FA
More news
Financials
Sales 2020 156 B 1 493 M 1 493 M
Net income 2020 19 528 M 187 M 187 M
Net cash 2020 109 B 1 040 M 1 040 M
P/E ratio 2020 39,2x
Yield 2020 0,77%
Capitalization 764 B 7 320 M 7 327 M
EV / Sales 2020 4,21x
EV / Sales 2021 4,04x
Nbr of Employees 3 435
Free-Float 62,2%
Chart KOBAYASHI PHARMACEUTICAL CO., LTD.
Duration : Period :
Kobayashi Pharmaceutical Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends KOBAYASHI PHARMACEUTICAL CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Average target price 9 118,57 JPY
Last Close Price 9 780,00 JPY
Spread / Highest target 11,5%
Spread / Average Target -6,76%
Spread / Lowest Target -23,3%
EPS Revisions
Managers
NameTitle
Akihiro Kobayashi President & Representative Director
Kazumasa Kobayashi Chairman
Noriaki Hirao Manager-Finance & Accounting
Haruo Tsuji Independent Outside Director
Satoshi Yamane Senior MD & Senior GM-Group Headquarters
Sector and Competitors
1st jan.Capitalization (M$)
KOBAYASHI PHARMACEUTICAL CO., LTD.5.50%7 320
THE PROCTER & GAMBLE COMPANY13.98%352 997
UNILEVER N.V.0.14%159 328
THE ESTÉE LAUDER COMPANIES INC.11.87%83 457
HINDUSTAN UNILEVER LIMITED13.15%69 419
COLGATE-PALMOLIVE COMPANY14.54%67 606